Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
936.00    -12.00 (-1.27%)
Bid:
934.00
Ask:
942.00
Spread: 8.00 (0.857%)
Market Cap: £256.19m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Full-Year Trading Update

4 Oct 2011 07:00

RNS Number : 4702P
Gooch & Housego PLC
04 October 2011
 



 

For immediate release

4 October 2011

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Full-Year Trading Update

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, today announces that results for the year ended 30 September 2011will be in line with market expectations. Preliminary results will be announced on 29 November 2011.

 

Favourable market conditions prevailed for the first three quarters of the year and strong demand was experienced across most market and product sectors. The acquisitions of EM4 and Crystal Technology during the second quarter contributed to revenue and profit growth and accelerated the diversification of the business. G&H's presence in the aerospace & defence, life sciences and telecommunications markets has been significantly enhanced, while the Company's market leadership in acousto-optics and electro-optics for industrial applications has also been reinforced. Given the fragile global economic environment we did anticipate some softening in demand in the final quarter, although this has been confined to certain product sectors and geographical markets. Greater diversification and growth in new markets has mitigated some of the effects of the slowing demand in other sectors.

 

The integration of the new acquisitions is progressing well. The rationale for G&H's acquisition of EM4 was demonstrated by a number of significant contract wins for strategic defence programs including the recent award of a $3+ million contract by a large US defence contractor for the first phase of the design, development and supply of fibre optic systems. Plans to duplicate G&H Torquay's passive fibre optics technology at EM4's Boston site, in order to access the large US aerospace & defence market for these products, are already well-advanced with the first products expected to be available for qualification testing in early 2012.

 

Crystal Technology has performed strongly during the first six months of G&H ownership, with revenues from all major markets exceeding original plan. The transfer of crystal growing from the Crystal Technology facility in Palo Alto to G&H's Cleveland operation - a major undertaking requiring the fitting out of a new 30,000 square foot facility - is making good progress. The facility is essentially complete and the first crystals have been grown. It is expected that production will be fully transferred by the end of the calendar year.

 

Gareth Jones, Chief Executive of Gooch & Housego commented: -

 

"During the past twelve months we have made progress towards achieving the key strategic and commercial objectives of greater diversification and strong organic and acquisitive growth. The uncertain economic climate will present challenges in the coming year but Gooch & Housego is well-positioned to deliver the next phase of its strategy as we seek to leverage the exceptional products, technologies and capabilities that the company now has to offer."

 

For further information please contact:

 

Gareth Jones/Andrew Boteler, 01460 256440

Tim Thompson/Nicola Cronk, Buchanan, 020 7466 5000

Patrick Robb/James Grace, Investec Bank plc, 020 7597 5970

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSDFMDFFSEDS
Date   Source Headline
9th May 20197:00 amRNSNotification of Half Year Results
30th Apr 20197:00 amRNSAppointment of Chief Financial Officer
9th Apr 20197:00 amRNSCapital Markets Day
9th Apr 20197:00 amRNSHalf Year Trading Update
28th Mar 20195:28 pmRNSDirector/PDMR Shareholding
28th Mar 20195:25 pmRNSDirector/PDMR Shareholding
28th Mar 20195:24 pmRNSDirector/PDMR Shareholding
25th Mar 20195:24 pmRNSDirector/PDMR Shareholding
13th Mar 20197:00 amRNSITL signs manufacturing agreement with OrganOx
25th Feb 201911:27 amRNSDirector Share Purchase
21st Feb 20192:58 pmRNSDirector Share Purchase
20th Feb 20191:07 pmRNSResult of AGM
20th Feb 20197:00 amRNSAGM Trading Update
9th Jan 201910:17 amRNSGrant of LTIP Awards
9th Jan 20197:00 amRNSSite Visit to ITL Life Science Business
28th Dec 201811:14 amRNSBlock Listing Six Monthly Return
28th Dec 201811:13 amRNSIssue of Equity and Total Voting Rights
28th Dec 201811:12 amRNSBlock Listing Application
11th Dec 20184:44 pmRNSAdditional Listing
11th Dec 20187:00 amRNSPosting of Annual Report and AGM Notice
5th Dec 201811:30 amRNSDirector/PDMR Shareholding
5th Dec 201811:28 amRNSDirector/PDMR Shareholding
27th Nov 201811:36 amRNSDirector/PDMR Shareholding
27th Nov 20187:00 amRNSCFO Succession
27th Nov 20187:00 amRNSPreliminary Results
30th Oct 201811:06 amRNSHolding(s) in Company
29th Oct 201811:08 amRNSHolding(s) in Company
25th Oct 20184:40 pmRNSHolding(s) in Company
25th Oct 20187:00 amRNSNotification of Preliminary Results
23rd Oct 201810:23 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSFull Year Trading Update
26th Sep 20189:00 amRNSHolding(s) in Company
6th Sep 20187:00 amRNSAerospace and Defence Acquisition
8th Aug 20187:00 amRNSLife Sciences Acquisition
12th Jul 20189:26 amRNSHolding(s) in Company
13th Jun 201810:08 amRNSHolding(s) in Company
6th Jun 20182:02 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSInterim Results
3rd May 20187:00 amRNSNotification of Half Year Results
6th Apr 20187:00 amRNSHalf Year Trading Update
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
20th Mar 20188:25 amRNSHolding(s) in Company
21st Feb 20185:20 pmRNSResult of AGM
21st Feb 20187:00 amRNSAGM Trading Update
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
22nd Jan 20181:00 pmRNSDirector/PDMR shareholding
18th Jan 20181:35 pmRNSGrant of LTIP Awards
22nd Dec 20179:13 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.